ACell, Inc. announced the introduction of Gentrix Incisional, a new implantable device comprised of the company's proprietary MatriStem UBM™ technology, designed to reinforce soft tissue in surgical site incisions. Gentrix Incisional is an extracellular matrix that facilitates the remodeling of site-appropriate, functional tissue where scarring would be expected. The device provides a scaffold for cellular infiltration and neovascularization, and can be used to reinforce primary closure of soft tissue in a variety of surgical settings.